Our previous results clearly demonstrated that different HDACi targeting HDAC classes I, IIa, and IIb effectively suppress HCV replication in regularly proliferating hepatoma cells [54,56]. This evidence concerns the gene HDAC9 and hepatocellular carcinoma.